ArticleCancer chemotherapy and pharmacology2024

Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma.

Sofia M Sousa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.